secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tarsus Pharmaceuticals, Inc. (TARS)
CIK:        0001819790
Form:       8-K
Filed at:   2023-06-27T23:59:59+00:00
Accession:  0001819790-23-000064
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tarsus shareholders elect three Class III directors, ratify E&Y as auditor
--------------------------------------------------------------------------

- Andrew Goldberg, Scott Morrison, Wendy Yarno elected to board until 2026 annual meeting.
- Director election votes: Goldberg 16.18M for, Morrison 14.67M, Yarno 16.56M; each had 4.98M broker non-votes.
- Ratification of Ernst & Young as independent auditor for FY 2023 passed with 22.17M for, 7,065 against.
- Annual meeting held June 22, 2023; 22.18M of 26.80M shares represented a quorum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819790/000181979023000064/0001819790-23-000064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819790/000181979023000064/tars-20230622.htm
  HTML page:      https://secwatch.observer/filing/0001819790-23-000064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer